Low-dose nesiritide improves renal function in heart failure patients following acute myocardial infarction

Heart and Vessels

Volumn 25, Issue 2, 2010, Pages 97-103

  Zhao, Qiang ^a   Wu, Tong Guo ^a   Lin, Yi ^a   Li, Biao ^a   Luo, Jing Yun ^a   Wang, Le Xin ^b  

^a GUANGZHOU RED CROSS HOSPITAL   (China)

^b CHARLES STURT UNIVERSITY   (Australia)

Author keywords

Angiotensin; Heart failure; Myocardial infarction; Nesiritide; Renal function

Indexed keywords

ALDOSTERONE; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN II; CREATININE; ENDOTHELIN; NESIRITIDE; NEUROHORMONE; NITROPRUSSIDE SODIUM; NORADRENALIN;

ACUTE HEART FAILURE; ACUTE HEART INFARCTION; ADULT; AGED; ANGIOTENSIN BLOOD LEVEL; ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFECT; DRUG MECHANISM; DRUG WITHDRAWAL; DYSPNEA; FEMALE; HEART FAILURE; HEART RATE; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HORMONAL REGULATION; HOSPITAL READMISSION; HUMAN; HYPOKALEMIA; HYPOTENSION; KIDNEY DISEASE; KIDNEY FUNCTION; LOADING DRUG DOSE; LOW DRUG DOSE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NORADRENALIN BLOOD LEVEL; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; URINE VOLUME;

AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CREATININE; FEMALE; HEART FAILURE; HEMODYNAMICS; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; NITROPRUSSIDE; PATIENT READMISSION; PEPTIDE FRAGMENTS; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 77950929284     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-009-1171-0     Document Type: Article

References (18)

1. A. Rossi G. Rossi M. Piacenti U. Startari L. Panchetti M.A. Morales 2008 The current role of cardiac resynchronization therapy in reducing mortality and hospitalization in heart failure patients: a meta-analysis from clinical trials Heart Vessels 23 217 223 10.1007/s00380-008-1039-8 18649051
2. T.M. Wei C.L. Zeng L.P. Chen Q.Y. Chen R.Y. Zhao G.X. Lu C.L. Lu L.X. Wang 2005 Bedside tests of B-type natriuretic peptide in the diagnosis of left ventricular diastolic dysfunction in hypertensive patients Eur J Heart Fail 7 75 79 10.1016/j.ejheart.2004.03.015 1:CAS:528:DC%2BD2MXitVensA%3D%3D 15642535 (Pubitemid 40092495)
3. A. Karavidas G. Lazaros E. Matsakas D. Farmakis J. Parissis I.A. Paraskevaidis C. Michailidis D. Avramidis A. Zacharoulis S. Arapi A. Kaoukis A. Zacharoulis 2008 Clinical value of B-type natriuretic peptide for the assessment of left ventricular filling pressures in patients with systolic heart failure and inconclusive tissue Doppler indexes Heart Vessels 23 181 186 10.1007/s00380-007-1022-9 18484161 (Pubitemid 351722408)
4. R.M. Mills T.H. Lejemtel D.P. Horton C. Liang R. Lang M.A. Silver C. Lui K. Chatterjee 1999 Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo controlled clinical trial J Am Coll Cardiol 34 155 162 10.1016/S0735-1097(99)00184-9 1:CAS:528:DyaK1MXmvFaltb8%3D 10400005
5. W.S. Colucci U. Elkayam D.P. Horton W.T. Abraham R.C. Bourge A.D. Johnson L.E. Wagoner M.M. Givertz C.S. Liang M. Neibaur W.H. Haught T. f. LeJemtel the Nesiritide Study Group 2000 Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure N Engl J Med 343 246 253 10.1056/NEJM200007273430403 1:CAS:528:DC%2BD3cXlvVSmtLw%3D 10911006 (Pubitemid 30490392)
6. The VMAC Investigators 2002 Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial JAMA 287 1531 1540 10.1001/jama.287.12.1531
7. W.F. Peacock C.L. Emerman M.A. Silver 2005 Nesiritide added to standard care favorably reduces systolic blood pressure compared with standard care alone in patients with acute decompensated heart failure J Emerg Med 23 327 331 10.1016/j.ajem.2004.11.002 (Pubitemid 40732268)
8. C.W. Yancy 2004 Treatment with B-type natriuretic peptide for chronic decompensated heart failure: insights learned from the follow-up serial infusion of nesiritide (FUSION) trial Heart Fail Rev 9 209 216 10.1007/s10741-005-6132-9 1:CAS:528:DC%2BD2MXivFelt7g%3D 15809819
9. D.J. Wang T.C. Dowling D. Meadows T. Ayala J. Marshall S. Minshall N. Greenberg E. Thattassery M.L. Fisher K. Rao S.S. Gottlieb 2004 Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine Circulation 110 1620 1625 10.1161/01.CIR.0000141829.04031.25 1:CAS:528:DC%2BD2cXnsVKqur8%3D 15337695 (Pubitemid 39297985)
10. J.D. Sackner-Bernstein H.A. Skopicki K.D. Aaronson 2005 Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure Circulation 111 1487 1491 10.1161/01.CIR.0000159340.93220.E4 1:CAS:528:DC%2BD2MXisVGrtLg%3D 15781736 (Pubitemid 40470642)
11. R.M. Witteles D. Kao D. Christopherson K. Matsuda R.H. Vagelos D. Schreiber M.B. Fowler 2007 Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized, double-blind, placebo-controlled clinical trial J Am Coll Cardiol 50 1835 1840 10.1016/j.jacc.2007.03.071 1:CAS:528:DC%2BD2sXht1GlurzM 17980248 (Pubitemid 350007964)
12. T.E. Owan H.H. Chen R.P. Frantz B.L. Karon W.L. Miller R.J. Rodeheffer R.J. Rodeheffer D.O. Hodge J.C. Burnett Jr M.M. Redfield 2008 The effects of nesiritide on renal function and diuretic responsiveness in acutely decompensated heart failure patients with renal dysfunction J Cardiac Fail 14 267 275 10.1016/j.cardfail.2007.12.002 1:CAS:528:DC%2BD1cXlvVSltL8%3D (Pubitemid 351636237)
13. R.J. Hillock C.M. Frampton T.G. Yandle R.W. Troughton J.G. Lainchbury A.M. Richards 2008 B-type natriuretic peptide infusions in acute myocardial infarction Heart 94 617 622 10.1136/hrt.2006.110239 1:CAS:528: DC%2BD1cXmsl2qtrg%3D 17639095 (Pubitemid 351580137)
14. H.G. Riter M.M. Redfield J.C. Burnett H.H. Chen 2006 Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction J Am Coll Cardiol 47 2334 2335 10.1016/j.jacc.2006.03.013 1:CAS:528:DC%2BD28Xmt1Kit7Y%3D 16750705 (Pubitemid 43795074)
15. E. Cediel B. Vazquez-Cruz J. Navarro-Cid N. de las Heras D. Sanz-Rosa V. Cachofeiro V. Lahera 2002 Role of endothelin-1 and thromboxane A2 in renal vasoconstriction induced by angiotensin II in diabetes and hypertension Kidney Int 82 S2 S7 10.1046/j.1523-1755.62.s82.2.x 1:CAS:528:DC%2BD3sXhs1Wht7g%3D (Pubitemid 35356988)
16. H. Kurata M. Takaoka Y. Kubo T. Katayama H. Tsutsui J. Takayama M. Ohkita Y. Matsumura 2005 Protective effect of nitric oxide on ischemia/reperfusion- induced renal injury and endothelin-1 overproduction Eur J Pharmacol 517 232 239 10.1016/j.ejphar.2005.05.026 1:CAS:528:DC%2BD2MXmtFGitr8%3D 15975571 (Pubitemid 40977900)
17. J.D. Sackner-Bernstein M. Kowalski M. Fox K. Aaronson 2005 Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials JAMA 293 1900 1905 10.1001/jama.293.15.1900 1:CAS:528:DC%2BD2MXjtl2gs7g%3D 15840865 (Pubitemid 40548187)
18. R.R. Arora P.K. Venkatesh J. Molnar 2006 Short and long-term mortality with nesiritide Am Heart J 152 1084 1090 10.1016/j.ahj.2006.07.002 1:CAS:528:DC%2BD28Xht12msLbM 17161057 (Pubitemid 44854791)